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Nonalcoholic fatty pancreas disease
ABHISHEK MATHUR, MEGAN MARINE, DEBAO LU, DEBORAH A. SWARTZ-BASILE,
ROMIL SAXENA, NICHOLAS J. ZYROMSKI & HENRY A. PITT
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
Abstract
Background. Obesity leads to fat infiltration of multiple organs including the heart, kidneys, and liver. Under conditions of
oxidative stress, fat-derived cytokines are released locally and result in an inflammatory process and organ dysfunction. In
the liver, fat infiltration has been termed nonalcoholic fatty liver disease, which may lead to nonalcoholic steatohepatitis. No
data are available, however, on the influence of obesity on pancreatic fat and cytokines, and nonalcoholic fatty pancreas
disease (NAFPD) has not been described. Therefore, we designed a study to determine whether obesity is associated with
increased pancreatic fat and cytokines. Materials and methods. Thirty C57BL/6J lean control and 30 leptin-deficient obese
female mice were fed a 15% fat diet for 4 weeks. At 12 weeks of age all animals underwent total pancreatectomy. Pancreata
from each strain were pooled for measurement of a) wet and dry weight, b) histologic presence of fat, c) triglycerides, free
fatty acids (FFAs), cholesterol, phospholipids, and total fat, and d) interleukin (IL)-1b and tumor necrosis factor-alpha
(TNF-a). Data were analyzed by Student’s t test and Fisher’s exact test. Results. Pancreata from obese mice were heavier
(pB0.05) and had more fat histologically (pB0.05). Pancreata from obese mice had more triglycerides, FFAs, cholesterol,
and total fat (pB0.05). Triglycerides represented 11% of pancreatic fat in lean mice compared with 67% of pancreatic fat in
obese mice (pB0.01). Cytokines IL-1b and TNF-a also were elevated in the pancreata of obese mice (pB0.05).
Conclusions. These data suggest that obese mice have 1) heavier pancreata, 2) more pancreatic fat, especially triglycerides
and FFAs, and 3) increased cytokines. We conclude that obesity leads to nonalcoholic fatty pancreatic disease.
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Introduction
Obesity has become epidemic in the United States,
with more than 50 000 000 Americans having a body
mass index (BMI)30 [1]. Obesity leads to multiple
comorbidities including diabetes, hypertension, and
hyperlipidemia (the metabolic syndrome). In addi-
tion, obesity causes fat infiltration of several organs
including the heart, kidneys, and liver. Under condi-
tions of oxidative stress, fat-derived cytokines are
released locally and result in an inflammatory process
and organ dysfunction. In the liver, fat infiltration has
been termed nonalcoholic fatty liver disease
(NAFLD), which may lead to nonalcoholic steatohe-
patitis (NASH) [2,3]. In addition, adipose tissue has
been characterized as an endocrine organ with in-
creased production of adipokines, including leptin
and adiponectin, and cytokines such as tumor necro-
sis factor alpha (TNF-a), interleukin-6 (IL-6), and
monocyte chemotactic protein-1 (MCP-1) [4].
Macrophages, in turn, produce IL-1b and myeloper-
oxidase (MPO), which further exacerbate the inflam-
matory process [4,5].
In 1920, Schaefer reported a correlation between
the weight of the adult pancreas and body weight [6].
In 1933, Ogilvie found 9% pancreatic fat in lean
cadavers compared with 17% pancreatic fat in obese
cadavers [7]. In the 1960s and 1970s fat in the
pancreas (pancreatic lipomatosis) was correlated with
age, obesity, and type 2 diabetes [8,9]. Recent com-
puted tomography (CT) and magnetic resonance
imaging (MRI) studies also have correlated pancreatic
fat with obesity [1012]. Human observations further
suggest that the severity of pancreatitis is increased in
obese patients [13,14]. Despite these observations,
nonalcoholic fatty pancreatic disease (NAFPD) and
nonalcoholic steatopancreatitis (NASP) have not been
described.
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Materials and methods
Animals and diets
Thirty lean control (C57BL/6J) and 30 obese leptin-
deficient (Lepob) female mice were obtained from
Jackson Laboratory (Bar Harbor, ME, USA). Lepob
mice are known to have islet cell hyperplasia, type II
diabetes, and elevated serum glucose and insulin,
suggesting pancreatic endocrine insufficiency [15,16].
The mice were housed five per cage in a light (6 am to
6 pm) and temperature (228C) controlled room.
During 1 week of environmental adjustment, the
mice were fed a standard low fat chow diet (Ralston
Purina, St Louis, MO, USA). At 8 weeks of age all the
lean C57BL/6J and the obese leptin-deficient (Lepob)
female mice were fed a low fat diet (15% fat,
45% carbohydrate, and 40% protein) (Dyets Inc.,
Bethlehem, PA, USA) for 4 weeks. The fat was
anhydrous milk fat; the carbohydrates were 35%
sucrose and 10% cornstarch; and the protein was
casein. Both the animals and the food were weighed
weekly to determine growth and dietary intake. All
protocols for these animal studies were approved by
the Indiana University Institutional Animal Care and
Use Committee.
Serum and tissue collection
At 12 weeks of age, after an overnight fast with water
allowed ad libitum , the mice were sedated with an
isoflurane-soaked gauze placed in a 2000 cm3 glass
jar. They were then anesthetized with an intraperito-
neal injection of xylazine (15 mg/kg) and ketamine
(50 mg/kg). The animals were weighed and then
underwent laparotomy and total pancreatectomy. A
slice of tissue from eight dorsal pancreata from each
strain was placed in formalin for measurement of
histologic presence of fat, inflammation, and fibrosis.
Seven pancreata from each strain were employed for
measurement of wet and dry weights. Sixteen dorsal
pancreata from each strain were pooled two per
group and snap frozen to 808C for measurement
of triglycerides, free fatty acids (FFAs), cholesterol,
phospholipids, and total fat. Seven dorsal pancreata
from each strain were snap frozen to 808C for
measuring cytokines IL-1b and TNF-a. Whole blood
was aspirated from the heart and centrifuged to isolate
serum.
Histologic analysis
Pancreatic specimens fixed in formalin were stained
with hematoxylin and eosin and were reviewed by an
observer who was blinded as to the groups. Each
specimen was graded, in five high powered fields, 0 to
4 for inter- and intralobular fat, inflammation, and
fibrosis. The total pancreatic fat score was calculated
as a sum of the inter- and intralobular fat. Figure 1A,
B shows a typical pancreas from a lean and an obese
mouse, respectively.
Serum analysis
Whole blood was spun at 15,000 rpm for 5 min to
separate serum. Serum was pooled to give six pools
for lean mice, and five pools were obtained for obese
mice. Serum cholesterol and triglycerides were deter-
mined by using an enzymatic colorimetric method for
their quantitative determination. The kits for these
measurements were obtained from Wako Chemicals
USA, Inc., Richmond, VA, USA and Stanbio Labs,
Boerne, TX, USA.
Gallbladder lipid analysis
Gallbladder lipids from eight pools from lean and
obese mice underwent lipid analysis at the Mouse
Metabolic Phenotyping Center at Vanderbilt Uni-
versity Medical Center, as previously described by
Goldblatt et al. [17]. Briefly, lipids were extracted by
Figure 1. (A) Typical pancreatic histology (A) of a lean mouse and (B) of an obese mouse (original magnification 10).
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the method of Folch-Lees [18]. Individual lipid
classes were separated by thin layer chromatography
using Silica Gel 60 A plates, and visualized by
rhodamine 6G. In addition, total cholesterol was
analyzed by the method of Rudel et al. [19]. An
aliquot of the Folch extract was saponified with 1 N
KOH in 90% methanol. The nonsaponifiable sterol
was extracted using hexane, and total cholesterol was
determined by gas chromatography.
Cytokine analysis
The cytokines IL-1b and TNF-a were measured in
seven pancreata from each strain by employing the
quantitative sandwich enzyme immunoassay techni-
que. The ELISA kit for this purpose was obtained
from R&D Systems, Inc. (Minneapolis, MN, USA).
Statistical analysis
Statistical analyses were performed using Sigma Stat
Statistical Software (Jandel Corp., San Rafael, CA,
USA). All data are expressed as mean9SEM. Differ-
ences in lean and obese mice body weight, food
intake, pancreas weights, serum lipids, pancreas
lipids, and cytokine data were tested for statistical
significance by Student’s unpaired t test. Differences
in pancreatic histology were tested for statistical
significance by Student’s unpaired t test and Fisher’s
exact test. A p value ofB0.05 was considered
statistically significant.
Results
Animal weights and dietary intake
As expected, the obese mice weighed significantly
more than the lean mice (4791 vs 1890 g; pB0.001)
at all time points. Dietary intake of the obese mice
also was significantly greater than that of the lean
mice (2292 vs 1691 g per week; pB0.01). The
obese mice did not develop exocrine insufficiency as
suggested by the absence of steatorrhea and weight
loss.
Pancreas weights and total fat
Pancreas dry weight and total fat in lean and obese
mice are presented in Figure 2. The pancreatic dry
weights were higher in the obese mice (pB0.05). The
pancreas wet weights also were higher in the obese
mice (161922 vs 8799 mg; pB0.01). The pancreas
total fat was increased four times in the obese mice
(pB0.001).
Pancreas histology
Pancreas histology is presented in Table I. No
significant differences in interlobular fat were seen
between the two groups. The obese mice had more
intralobular and total pancreatic fat than lean mice
(pB0.05). A higher percentage of obese mice had
increased pancreatic fat scores (]1) (88% vs 25%;
pB0.05). No inflammation or fibrosis was seen in
either group.
Serum data
Serum cholesterol and triglycerides are presented in
Figure 3. Serum cholesterol was increased in the
obese mice (208917 vs 7896 mg/dl; pB0.001).
However, serum triglycerides were not increased in
the obese mice (6694 vs 7496 mg/dl).
Pancreas individual fat analysis
Cholesterol, triglycerides, and phospholipids. Pancreas
cholesterol and triglycerides are shown in Figure 4.
The obese mice had more cholesterol and triglyceride
in their pancreata compared with their lean counter-
parts (pB0.05). Cholesterol esters followed the
same pattern and also were significantly (pB0.001)
increased in the obese mice (0.490.02 vs 0.19
0.03 mg/mg). Phospholipids were no different in obese
and lean mice (2090.8 vs 2391.3 mg/mg).
Free fatty acids. Pancreas FFAs and saturated fatty
acids are shown in Figure 5. Both were increased four-
fold in obese compared with lean mice (pB0.001).
Individual FFA chains are shown in Table II. Ten of
the 14 FFA chains including saturated, monounsatu-
rated, and polyunsaturated FFAs were increased in
the obese mice (pB0.05).
Figure 2. Pancreas dry weights in milligrams and total pancreatic
fat by lipid analysis.
Table I. Histology of pancreata.
Study
group
Interlobular
fat
Intralobular
fat
Total
fat
Pancreatic
fat
Lean mice 0.390.2 0.190.1 0.490.3 25%
Obese mice 0.990.4 1.190.4* 2.390.7* 88%
*pB0.05 vs lean mice.
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Cytokine analysis
Levels of IL-1b and TNF-a are shown in Figure 6.
Both cytokines were significantly elevated in obese
compared with lean mice (pB0.05).
Discussion
In this study 30 lean C57BL/6J and 30 leptin-
deficient obese (Lepob) female mice were fed a low
(15%) fat diet for 4 weeks. The pancreata of the obese
mice were heavier than those of their lean counter-
parts. On histologic examination the intralobular and
total pancreatic fat was significantly increased in the
obese mice. Serum cholesterol, but not triglycerides,
was elevated in the obese mice. Pancreatic lipid
analysis revealed markedly increased total fat, trigly-
cerides, and FFAs as well as significantly increased
cholesterol in the obese mice. No strain differences
were seen in levels of pancreatic phospholipids. The
saturated fatty acid chains 14:00 and 16:00 were
increased fivefold in the obese mice; 18:00 was
increased 2.5-fold in the obese mice. The unsaturated
fatty acids that were increased more than four times in
the obese mice included 16:01, 18:01, 18:02, and
18:3w3. The cytokines IL-1b and TNF-a also were
significantly elevated in the pancreata of obese mice.
Since Ogilvie [7] first postulated the entity of
pancreatic fat infiltration, more sophisticated radiolo-
gic techniques have backed up this claim [1012].
Interestingly, fat in the pancreas is not distributed
homogeneously throughout the gland [10]. Matsu-
moto et al. proposed a classification of pancreatic fat
infiltration based on the sparing of fat in the posterior
aspect of the head of the pancreas, the uncinate, and
the area around the common bile duct. Differences in
the embryologic development of the ventral and
dorsal pancreatic buds has been proposed as the
cause [10]. Further refinements of the process of
quantification of fat have come with MRI. Using the
3-point Dixon technique, Kovanlikaya et al. have
reconfirmed the correlation of BMI and pancreatic
fat [12].
Increased infiltration of fat in the pancreas has been
associated with obesity, increased age, Cushing’s
syndrome, cystic fibrosis, and lipomatous pseudohy-
pertrophy [7,8,20]. Dreiling et al. postulated that fat
infiltration of the pancreas was a reversible process
[21]. In addition, Nghiem et al. have shown that the
fatty pancreas observed in obesity can be ‘defatted’
and used successfully for pancreas transplantation
[22]. However, extreme fatty replacement of the
exocrine pancreas is likely to be associated with a
decrease in pancreatic function. Massive fatty repla-
cement has been described in the entity of lipomatous
Figure 3. Serum cholesterol and triglycerides.
Figure 4. Pancreatic tissue cholesterol and triglycerides.
Figure 5. Pancreatic tissue free fatty acids (FFAs) and saturated.
Table II. Pancreas individual free fatty acid chains.
Free fatty
acid chains
Lean mice
(mg/mg)
Obese mice
(mg/mg)
14:00 0.0390.01 0.1690.02*
16:00 0.4090.12 1.9090.14*
18:00 0.1290.02 0.3190.02*
16:01 0.0890.03 0.7390.07*
18:01 0.4590.13 1.7490.13*
18:02 0.0790.02 0.5790.05*
18:3w3 0.0190.01 0.0790.01*
20:3w9 0.0190.00 0.0090.00$
20:3w6 0.0090.00 0.0190.01
20:04 0.1190.01 0.1390.01
20:05 0.0090.00 0.0190.00
22:04 0.0090.00 0.0190.00$
22:05 0.0090.00 0.0190.01$
22:06 0.0290.00 0.0390.01
Values are the mean9SEM.
*pB0.001 vs lean mice; $pB0.05 vs lean mice.
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pseudohypertrophy of the pancreas [9,20]. Interest-
ingly, pancreatic islet cells are resistant to fatty
infiltration [9,20].
Adipose tissue is not an innocent bystander of the
metabolic syndrome. Fat, and particularly visceral fat,
is now known to play a key role in the metabolic
dysfunctions that occur as a consequence of obesity.
Adipose tissue produces adipokines, chemokines, and
cytokines, which are collectively referred to as adipo-
cytokines [4,5]. In the lean adult these adipokines,
like leptin and adiponectin, play a role in normal body
metabolism. However, in humans obesity leads to an
increase in leptin and a decrease in adiponectin
production by fat cells. This altered adipokine milieu
leads to monocyte and macrophage infiltration into
the fat [4]. We have shown that leptin-deficient obese
mice have increased fat and cytokines in their
pancreas. However, white blood cell infiltration was
not different in the two groups. Thus, the alteration in
the individual fats may have resulted in increased IL-
1b and TNF-a. In adipocytes triglycerides, which
were markedly increased in the obese pancreata, have
been linked to increased production of TNF-a [23].
In addition, the literature on atherosclerosis suggests
that increased cholesterol in endothelial cells stimu-
lates IL-1b production [24]. Moreover, we have
recently demonstrated a similar phenomenon in
the gallbladder of leptin-deficient obese mice [25].
The consequences of the elevation of tissue cytokines
are an increase in insulin resistance, lipolysis, fat
oxidation, and angiogenesis [4,5,26]. One of the
results of this chain of events is an increase in FFA
levels in both serum and tissue.
In this study we have shown a fourfold increase in
the pancreatic tissue levels of FFAs. As adipocytes
enlarge, free fatty acids are released from omental and
peripheral fat [4]. FFAs then potentiate their own
release by inducing insulin resistance which, in turn,
increases lipolysis [2,3,27,28]. Furthermore, elevated
serum FFAs have been shown to increase triglyceride
accumulation, activate the pro-inflammatory NF-kB
pathway, and increase tissue cytokines and reactive
oxygen species (ROS) in animal studies [2729].
Human studies also have correlated serum FFAs with
elevated serum cytokines [30,31]. Delving deeper into
the individual FFA chains, Suganami et al. observed
that saturated fats, and not polyunsaturated fats, were
capable of inducing cytokine production from macro-
phages in adipose tissue [32]. In humans, the only
fatty acids that correlate with serum cytokine levels
are palmitate and myristic acid, both saturated fats
[30]. A further indictment of palmitate comes from
animal studies showing that it activates the NF-kB
pathway and induces IL-6 and TNF-a in adipocytes
and ROS in endothelial calls [33,34]. Palmitate is also
essential for the synthesis of ceramide, which is known
to mediate inflammation [35]. In the present study we
found a more than fourfold increase in both palmitic
(16:00) and myristic acid (14:00) levels in the obese
versus lean murine pancreata. Among the unsaturated
fatty acids, palmitoleic (16:01), oleic (18:01), and
linoleic (18:02) acid were also found to be substan-
tially elevated in obese mice. Both oleic and linoleic
acid have also been shown to have proinflammatory
effects [36,37].
We have previously shown that Lepob mice have
increased fat in their liver without inflammation or
fibrosis (NAFLD) [38]. Our observations with respect
to NAFPD are similar to those for NAFLD in that
obesity leads to significant tissue triglyceride accumu-
lation. We postulate, therefore, that the fatty pancreas
may be more prone to pancreatitis similar to the
development of nonalcoholic steatohepatitis (NASH)
from NAFLD [39]. If this phenomenon was to occur
in the pancreas, the term nonalcoholic steatopancrea-
titis (NASP) might apply. With NASH a two-hit
theory has been postulated. The first hit is triglyceride
accumulation as a result of both an increase in dietary
FFAs and lipolysis in peripheral fat tissue [2,39]. Our
model of NAFPD showed that triglycerides were
dramatically elevated, going from 3 mg/mg in lean to
63 mg/mg in obese mice, a 20-fold increase. The
second hit is believed to occur as the result of an
oxidative stress. Elevated insulin levels are known to
generate oxidative stress and fibrogenesis [2]. Pre-
vious studies from our laboratory have demonstrated
that Lepob mice have hyperglycemia, hyperinsuline-
mia, and hyperlipidemia [16]. Lipid peroxidation is
the other important mediator of the second hit, with
FFAs being the major source [2]. The primary site of
lipid peroxidation is the mitochondria. In the pan-
creas of patients with type II diabetes mellitus
mitochondrial dysfunction, which leads to increased
oxidation and generation of ROS, has been documen-
ted [40]. Lending more credence to our theory are the
recent data from Yan et al., who have shown that a
high fat diet in rats increases lipid peroxidation
and ROS and decreases pancreatic microcirculation
[41]. These changes would result in an inflammatory
state which we have termed NASP. Further studies
Figure 6. Pancreatic tissue interleukin (IL)-1b and tumor necrosis
factor alpha (TNF-a).
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measuring tissue malon-dialdehyde (MDA) will be
required to determine whether obese mice have
increased oxidative stress and are more prone to
NASP.
Obesity leads to NAFLD, which may progress
to NASH, cirrhosis and, ultimately, hepatocellular
cancer [2,3]. Obesity, and importantly central obesity,
also has been associated with a significantly increased
risk of pancreatic cancer [42]. Increased pancreatic
fat and, in particular FFAs, may play a role in
the progression of NASP to cancer. Supporting
this hypothesis, a high fat diet has been shown to
enhance the risk of pancreatic cancer in both humans
and animal models [43,44]. Ghadrian et al. and
Stolzenberg et al. also have reported that increased
dietary saturated fat intake increases the risk of
pancreatic cancer [45,46]. In addition, Fisher et al.
showed that serum elevations of FFAs correlate
with both in vivo and in vitro tumor growth [47].
Additionally, they showed that linoleic and oleic
acid cause a dose-dependent increase in pan-
creatic cell growth. Both of these fatty acids were
elevated in the pancreata of the obese mice in our
study. Further studies will be required, however, to
determine whether congenitally obese mice with
increased pancreatic fat are more prone to pancreatic
cancer.
This study documents that obese mice have heavier
pancreata and more pancreatic fat, especially trigly-
cerides and FFAs, as well as increased cytokines.
We conclude that obesity leads to fat infiltration
of the pancreas, which can be termed nonalcoholic
fatty pancreatic disease. This observation may have
implications regarding the severity of pancreatitis
in obese patients as well as the association of obesity
with pancreatic cancer. Thus, the accumulation of
toxic fats and proinflammatory cytokines in the
pancreas, steatopancreatitis, may be key to the patho-
genesis of both pancreatitis and pancreatic cancer.
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